Search

everythinglearnresearchcommunity

for

Search:↓

The guidelines help doctors manage skin problems from certain cancer treatments to improve patients' lives.

Targeted cancer therapies can cause skin side effects, which should be treated early to help patients' quality of life and treatment adherence.

JAK inhibitors may become the first approved treatment for alopecia areata if they are proven safe and effective.

Targeting Keratin 17 may help overcome cancer therapy resistance.

Surgical excision is the best treatment for SCC.

Deucravacitinib did not significantly improve hair regrowth in alopecia areata patients.

Deuruxolitinib is FDA-approved for treating severe alopecia areata.

Baricitinib combined with other immune therapies may safely and effectively treat severe scalp hair loss.

Vismodegib effectively treats advanced basal cell carcinoma but requires careful management of serious side effects.

Deuruxolitinib significantly helps regrow scalp hair in adults with moderate to severe alopecia areata.

Bevacizumab may worsen hypothyroidism, so thyroid function should be monitored during treatment.

Cepharanthine helps reduce cell aging caused by the cancer drug Doxorubicin by boosting cell cleanup processes.

5α-reductase inhibitors may lower the risk of death from bladder cancer.

Skin side effects from CDK4/6 inhibitors in breast cancer patients are generally mild and treatable, allowing most patients to continue treatment.

A man with vitiligo and alopecia saw quick skin and hair improvement with ruxolitinib, but skin color gains were lost after stopping treatment.

Minocycline reduces acne rash, pyridoxine lowers hand-foot syndrome risk, and scalp cooling lessens hair loss from cancer treatments.

The document concludes that individualized treatment for malignant epithelial tumors is necessary and more research on metastatic squamous cell carcinoma treatments is needed.

Switching immunosuppressants can improve hair regrowth and well-being in transplant patients experiencing hair loss.

Janus kinase inhibitors are effective and generally safe for treating hair loss in adults with alopecia areata.

Renal transplant patients on tacrolimus and sirolimus may develop acne keloidalis nuchae.

Baricitinib for severe alopecia areata is generally safe, with common side effects like infections and acne, and low rates of serious complications.

Erlotinib can cause acne-like skin issues, needing early treatment and possible dosage adjustments.

PRIDE syndrome helps identify skin side effects from EGFR inhibitors like erlotinib.

A rare skin reaction from cancer treatment was successfully managed with topical treatments and antihistamines.

Cyclosporin effectively and safely treated skin diseases in three pets with no side effects.

Tofacitinib and low-dose IL-2 may help maintain hair regrowth in alopecia areata without ongoing treatment.